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A Literature Review on Quality of
Care and Cost Issues
Jane H. Lassetter, MS, RN; Myrna L. Warnick, MSN, RN
Medical errors have received a great deal of attention in recent years. The phrase medical errors
is an umbrella term for all errors that occur within the health care system, including mishandled
surgeries, diagnostic errors, equipment failures, and medication errors. This article is a review and
discussion of the literature on the scope of medical errors, with a focus on drug-related problems
and medication errors. Cost and quality ideas for addressing these issues are provided. Key words:
drug-related problems, medical errors, medication errors

M

EDICAL ERRORS have received a great
deal of attention in recent years. Inconvenience, pain, suffering, and even death have
been connected with medical errors. In addition, there is a huge financial burden associated with these errors. The phrase medical
errors is an umbrella term for all errors that
occur within the health care system, including mishandled surgeries, diagnostic errors,
equipment failures, and medication errors.1
(See Table 1 for a summary of terms and definitions discussed.) This article is a review and
discussion of the literature on the scope of
medical errors, with a focus on drug-related
problems and medication errors.
MEDICAL ERRORS
In November 1999, the National Academy
of Sciences’ Institute of Medicine (IOM) focused national attention on the issue of errors

within the health care system of the United
States (US) in a report entitled, “To Err is Human: Building a Safer Health Care System.”
In terms of health care dollars, medical errors have been estimated to cost $5 million
per year in large teaching hospitals.5 The cost
to the U.S. economy is $17 to $29 billion
each year, with direct health care costs accounting for half of these expenses.6 Additionally, it is estimated that medical errors injure
1 out of 25 hospital patients in the United
States. The IOM report stated that 44 000 to
98 000 hospitalized patients die from medical
errors yearly. Even the lower estimate would
mean that more people die each year from
medical errors than from motor vehicle accidents (43 458), breast cancer (42 297), or
AIDS (16 516). By these estimates, medical errors are the eighth leading cause of mortality
in the United States.1
DRUG-RELATED PROBLEMS

From the College of Nursing, Brigham Young
University, Provo, UT, USA.
Corresponding author: Jane H. Lassetter, MS, RN, College of Nursing, Brigham Young University, 500 SWKT,
Provo, UT 64602 (e-mail: jane lassetter@byu.edu).

In 1995 Johnson and Bootman cast a wide
net in their landmark decision-analytic model
on drug-related problems that result in drugrelated morbidity and mortality. Drug-related
problems identified in their model included
175
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Table 1. Definitions of terms
Term
Medical errors
Drug-related problems

Medication error

Adverse drug reaction
Adverse drug event
Noncompliance

Definition
Errors that occur within the health care system, including mishandled
surgeries, diagnostic errors, equipment failures, medication errors1
Circumstances involving pharmaceutical treatment that interfere with
optimal outcomes and result in worsening medical outcomes,
including overdosage, subtherapeutic dosage, adverse drug reactions,
and failure to receive drugs (noncompliance) for a variety of reasons2
A preventable mistake in prescribing or delivering medication to a
patient, that is, an improper use of medicine or one that causes harm to
a patient1,3
An excessive response to a medication that is undesired or unexpected.1,3
This excludes events associated with error4
Nonpreventable and preventable injuries due to use of drugs4
Failure to receive drugs for a variety of reasons, including economic,
cultural, sociological, psychological, and pharmaceutical

overdosage, subtherapeutic dosage, improper
selection of a drug to treat a patient’s condition, adverse drug reactions, drug interactions, taking a drug for which there is no legitimate medical indication, not receiving a
drug for which there is compelling medical indication of need, and failure to receive drugs
(noncompliance) for a variety of reasons,
including psychological, sociological, and
economic.7 Left unrecognized and/or unresolved, these drug-related problems can lead
to drug-related morbidity and mortality. In
some cases, no treatment is needed. When
treatment is required, it can range from a
physician visit to an emergency department
visit to a hospital admission and long-term
care. On the basis of expert input, Johnson
and Bootman estimated the costs and probabilities associated with drug-related morbidity
and mortality.2,8
Johnson and Bootman estimated the direct cost of managing drug-related morbidity
and mortality in the ambulatory setting to be
$76.6 billion per year in the United States.
The cost of drug-related hospitalizations accounted for 62% of their total cost estimate,
with approximately 8.76 million admissions
annually at a cost of $47.4 billion.2 More re-

cently, Ernst and Grizzle have updated cost estimates based on Johnson and Bootman’s 1995
model. Their results show that cost of drugrelated problems among ambulatory Americans has more than doubled and is now at
$177.4 billion annually. Hospital admissions
are responsible for $121.5 billion or 69% of
this total cost.8
The discrepancy between the $29 billion
estimated by the IOM for all medical errors and the over $177 billion estimated by
Ernst and Grizzle using the Johnson and Bootman model on drug-related problems needs
to be carefully analyzed. From the literature,
one can extrapolate that Johnson and Bootman used a more comprehensive community
model than the IOM did when examining actual event costs.
Johnson and Bootman identified preventable drug-related morbidity and mortality
as a critical medical problem in urgent need
of expert attention. They maintained that a
significant portion of drug-related morbidity
and mortality results from inappropriate
behaviors and is, therefore, preventable.
A modest 10% reduction in inappropriate
behaviors (ie, improper prescribing and/or
inadequate monitoring of patient conditions
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by health care professionals and patient
non-compliance) would result in significant
savings to the health care system. They
supported the practice philosophy of pharmaceutical care, involving implementation
and monitoring of patient-oriented therapeutic plans. Goals of such efforts include
prevention of drug-related problems where
possible and early identification and resolution of problems that could not be prevented.
Specifically, they advocated for enhanced
pharmaceutical services and pharmaceutical
involvement in an interdisciplinary team
approach to patient care, feasibly leading to
improved detection of problems and overall
reduction in drug-related problems.2
On the basis of Johnson and Bootman’s
conclusions2 and using their estimated cost
of $76.6 billion for drug-related morbidity and
mortality, Penna9 extrapolated the potential
savings to be found in reducing these costs
through more fully integrating pharmaceutical experts into patient care. Penna9 stated
that estimated amount spent on drug-related
morbidity and mortality is just slightly more
than the cost of the medications themselves.
On the basis of data from a panel of pharmaceutical experts, Johnson and Bootman2
suggested that up to 60% of patients who
receive medication experience drug-related
problems in a typical ambulatory setting in
which pharmacists were not providing the
proposed level of care as described above.
On the basis of this estimate, Penna deduced
that up to 60% of drug-related morbidity and
mortality are preventable. If this is correct
and assuming an approximate equivalency between medication costs nationally and costs
of drug-related morbidity and mortality, Penna
calculated the following cost savings: Given
an average medication cost of $18 per member per month (PMPM) for a managed care organization (MCO), and that drug-related problems resulting in morbidity and mortality cost
an equivalent $18 PMPM, a program aimed
at reducing these problems could optimally
save $10.80 PMPM (60% of $18 PMPM). Few
initiatives have such great potential for costcontrol and quality improvement as efforts

177

that can effectively and efficiently address this
problem.9
MEDICATION ERRORS
A medication error is defined as a preventable mistake in prescribing or delivering
medication to a patient, that is, an improper
use of medicine or one that causes harm to
a patient. It differs from an adverse drug reaction, which is defined as an excessive response to a medication that is undesired or
unexpected.1,3 Medication errors are a very
common type of medical error. Of all medical errors, medication errors, specifically, are
estimated to increase hospital costs in the
United States by about $2 billion annually.10
Deaths from medication errors are estimated
to be about 7000 per year.11 A recent survey
of 300 health care professionals conducted by
HCPro, a health care management and regulatory information company, examined the nature and frequency of medical errors. Results
of this survey implied that 30.5% of deaths
from medical errors were attributable to medication errors. Ninety-four percent of the respondents to the HCPro survey further indicated that medication errors had occurred
at their health care facilities within the past
year. Sixty-four percent identified medication
errors as the most common medical error at
their facility.7 Results of a study by the Agency
for Healthcare Research and Quality (AHRQ)
discovered that medication errors accounted
for 20% of medical errors that resulted in injury or death.12
Although medication error is just one classification of medical error, these data illustrate the significant impact of this type of
error. As medication errors are more controllable and, thus, more easily addressed
than drug-related problems, perhaps the major focus should be here. Because medication
errors are multidisciplinary in nature, they
can occur anywhere along the health care
continuum,13 resulting in a dilemma with a
wide scope. Table 2 summarizes the types of
medication errors identified in review of the
literature.
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Table 2. Medication errors referred to in the literature
Type of medication error

Reference

Prescribing 2 or more medications whose interaction is
known to cause side effects
Prescribing a drug to which the patient has a known
allergy
Misreading a physician’s handwriting
Misinterpretation of an abbreviation
Confusion between 2 similarly named medications
Using a concentrated dose of medication instead of a
dilute form
Switching of different medications in similar-looking
packaging
Unclear dosage directions that result in excessive or
insufficient doses or incorrect timing of administration
Omission error

Specific methods of curtailing medication
errors need to be identified. In order to accomplish this, medication systems need to
be examined. Delivery of medication requires
completion of at least 5 interdependent steps:
ordering, transcribing, dispensing, delivering,
and administering. There are numerous opportunities for errors in any of these steps.10
Leape and associates14 found that 39% of
errors occurred in physician orders followed
closely by 38% in nurse administration of the
drug. Remaining errors were divided almost
equally between transcription and dispensing. A study in 2 tertiary care hospitals by
Bates and associates found errors that were
common in specific steps of the process.
Ordering and administering medications accounted for 56% and 34%, respectively, of the
preventable medication errors.15
Research has demonstrated that targeting
the systems that incorporate the steps involved in delivery of medication will yield the
best results.16 One study by Bates and associates attempted to identify patient risk factors for medication errors but discovered few
such factors. They found that sicker patients
with longer lengths of stay experienced ad-

AHRQ1
AHRQ1
American Society of Health-System
Pharmacists3
American Society of Health-System
Pharmacists3
American Society of Health-System
Pharmacists3
American Society of Health-System
Pharmacists3
American Society of Health-System
Pharmacists3
American Society of Health-System
Pharmacists3
O’Shea13

verse drug events more frequently, but few
risk factors surfaced after controlling for level
of care and preevent length of stay. These
researchers also suggested that a focus on
improving medication systems would likely
prove more effective than seeking to identify
patient risk factors.4
Leape and associates14 concluded that the
vast majority of medication errors were due to
system failures, with problems in drug knowledge dissemination being the most common
system error (29%). Many physician prescription errors appeared to have been caused by
lack of knowledge about the medications and
their proper usage. Errors associated with dosing were by far the most common. Nurses also
made errors related to lack of knowledge, but
these were less frequent and less likely to do
harm.14
System factors specifically surrounding
nursing have been identified as contributing
to medication errors. In research conducted
in Alaska, Roseman and Booker’s findings indicated that medication errors were positively
associated with the number of shifts worked
by temporary staff and negatively associated with the number of overtime shifts by
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permanent staff. These authors suggested that
despite the accompanying fatigue of overtime
shifts, they were more likely to be worked by
experienced nursing staff. In contrast, temporary staff may be less experienced, resulting in higher error rates.17 Additionally, Leape
and associates14 noted that staffing deficiencies and excessive workloads are thought to
be causes of a large number of errors.
Many health care institutions have recognized that patients face a needlessly high risk
of injury from medication errors. A report
on a collaborative effort to reduce medication errors in Utah and Nevada found that
most errors are caused by complex systems
that place exceptional demands on human
memory, attention, and vigilance; poorly standardized procedures for the use of medications; and poor communication between personnel within the system.18 These authors
concluded that the most significant change
brought about by quality improvement activities may have been enhancement of the safety
cultures in participating institutions. In other
words, how tolerant an institution was toward
error or potential error affected how likely
people were to report them.18
Leape would agree with this conclusion
since he stated, “the most important thing
that can be done to prevent errors is to
create a nonpunitive environment in which
people do not get punished for making
mistakes.”16(p283) Leape explains that unless
such an environment exists, people will not
report the errors that they can hide, making
it difficult to identify errors, let alone prevent
them from happening. He further stated that
one of the reasons for our high rate of medical
errors is the “train and blame”culture we have
created in health care. In this culture, people
are highly trained and held to very rigorous
standards and are expected to make no errors.
When mistakes occur, people are punished.
But errors are made by competent, careful individuals simply because people sometimes
make mistakes. He said that motivation to hide
mistakes is a particular problem in nursing
because most states have regulations that require suspension or loss of a nursing license
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when certain errors are made.16 Leape stated,
“Such regulations are ill-founded and need to
be changed.”16(p285)
In an effort to improve reporting of errors, Baylor Health Care System implemented
a systems approach that increased employee
satisfaction, reduced costs, and enhanced error reporting. Baylor leadership’s strong belief
that gathering data on adverse events would
help identify gaps in hospital systems and processes helped them in creating an atmosphere
of safety that encouraged error reporting.
Other key factors to their success included an
easy-to-use Web-based reporting system, feedback to staff on patient safety data, and financial and nonfinancial incentives for staff who
reported errors.19
Work design also has an impact on errors
that are made. Leape explained that experience in other industries, particularly aviation
and nuclear power, has taught that a major factor in the mistakes people make is the way in
which their work is designed. Leape asserted
that rules and checks are rather ineffectual instruments in preventing errors. For example,
he points out that all of the double-checking
of medications did not do nearly as much to
reduce errors as the initiation of unit-dosing,
because unit-dosing accomplished a system
change that provided the correct dose rather
than requiring nurses to constantly calculate
and measure doses.16
Efforts to improve communication have
also been effective in reducing errors. For
instance, the involvement of pharmacists in
rounds has been shown to reduce medication
errors significantly.20 Computerized prescribing also helps decrease medication errors by
eliminating the need for handwriting. Other
ways computerized prescribing can help reduce medication errors are helping the physician select an appropriate medication based
on prescription regimens from accepted clinical guidelines and screening for allergies and
interactions (provided there is a link between
pharmacy and clinical data).21
Computerized order entry has been shown
to be effective in practice. For instance, computerized order entry was implemented at the
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Hospital for Sick Children in Toronto in 1993
and improved in 1996 for the pediatric intensive care unit. This process change has contributed significantly to the decrease in medication errors at this institution.22
Although the primary motivation for computerized order entry should be to improve
the quality of patient care, the financial aspects of implementation and maintenance of
such systems must be considered. Pressure for
full implementation of computerized order
entry in the United States is mounting from
consumer consortiums such as the Leapfrog
Group, which estimates over 500 000 serious medication errors a year could be prevented and $549 million annual savings nationwide from such efforts.23 Implementation
costs vary according to the size of hospital and the capabilities of the existing clinical information systems at a specific facility. Initial cost estimates range from $496 000
(with $174 000 for annual maintenance of
small hospitals with clinical information systems with electronic order entry capabilities)
to nearly $15 million (with $1.5 million for

annual maintenance of large hospitals that require a new clinical information system).23
Communication via the prescription label
may also be helpful. The Food and Drug Administration has proposed a new prescription
drug-labeling format for newer, less familiar
medications that would be more user-friendly
and provide health care professionals with
bulleted highlights on product information.24
Iatrogenic injury and death from medication errors and drug-related problems leading to drug-related morbidity and mortality are significant problems in the health
care system today. Errors, by definition, are
preventable. Drug-related problems can also
be diminished through prevention, identification, and resolution. These issues need to be
addressed on an institutional, state, and national levels. Many system errors have been
identified, but Leape suggests that there are
1000 more system changes waiting to be
found.16 As faults in the medication system are
identified and corrected, thousands of lives
and billions of health care dollars will be
saved.
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CE TEST QUESTIONS
General Purpose: To present a literature review on the scope of medical errors, focusing
on drug-related problems and medication mishaps
and to suggest strategies for addressing these
issues.
Learning Objectives: After reading this article
and taking this test, you’ll be able to:
1. Outline the demographics of medical errors, including etiology, cost, and overall impact.
2. Describe the pertinent findings from previous research related to medical errors.
3. List at least four initiatives aimed at reducing
medication errors.
1. In the U.S., medical errors represent the
a. third leading cause of death.
b. fifth leading cause of death.
c. eighth leading cause of death.
d. tenth leading cause of death.
2. A 2001 estimate by Ernst and Grizzle indicated that medical errors
now cost about
a. $29 billion each year.
b. $71 billion each year.
c. $122 billion each year.
d. $177 billion each year.
3. Johnson and Bootman attribute a
significant portion of drug-related
morbidity and mortality to
a. inappropriate prescribing and monitoring
behavior.
b. the vast spectrum of adverse effects of drug
therapy.
c. the use of less expensive generic formulations.
d. the lack of patient education about the
risks of drug therapy.
4. Penna believes that the key to
reducing medication-induced morbidity and mortality is
a. drug research focused on reducing
adverse complications.
b. initiatives that promote patient education
about the possible adverse effects of drug
therapy.
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5.

6.

7.

8.

9.

c. increased involvement of pharmaceutical
experts in patient care.
d. increased nursing hours dedicated to
medication monitoring.
By definition, an adverse drug reaction is
a. preventable.
b. either undesired or unexpected.
c. an erroneous delivery of a drug to a patient.
d. an improper use of a medication.
According to the Agency for
Healthcare Research and Quality (AHRQ), how many deaths from
medical errors result from medication errors?
a. 10%
c. 30%
b. 20%
d. 40%
Of the following independent steps
in delivering drug therapy to a patient, which has been identified in
two recent studies as accounting
for the greatest percentage of errors?
a. prescribing
c. dispensing
b. transcribing
d. administering
In a study by Bates and colleagues
of patient risk factors for medication errors, the researchers found
the highest frequency of medication errors among patients
a. with limited understanding of drug therapy.
b. in long-term care facilities.
c. receiving multiple medications.
d. with longer lengths of stay.
Of the following, which system error did Leape and colleagues find
to be the most common?
a. excessive workloads
b. lack of standardization
c. problematic drug knowledge dissemination
d. inadequate monitoring

10. According to Roseman and
Booker, which of the following
nursing-related problems correlated with the greatest number of
medication errors?

a.
b.
c.
d.
11.

12.

13.

14.

15.

poor staffing ratios
overtime shifts worked by permanent staff
inadequate drug inservice education
higher numbers of shifts worked by
temporary staff
According to a study of medication
errors in Utah and Nevada, medication errors are a result of medication-use procedures that are
a. poorly standardized.
b. overly complex.
c. outdated.
d. not easily accessed.
Leape has stated that the most important thing that can be done to
prevent errors is to
a. simplify existing medication systems.
b. stop punishing people for making mistakes.
c. increase the amount of continuing education required.
d. raise the standards of entry-level medication knowledge for nurses.
The environment of safety created
at Baylor Health Care System primarily encouraged staff to
a. reduce costs.
b. simplify medication administration.
c. report errors.
d. enhance patient monitoring systems.
Which system change does Leape
believe has been most effective in
reducing medication errors?
a. double-checking orders
b. initiating unit dosing
c. co-signing for medication administration
d. initiating computerized documentation
of medication administration
Which initiative has had the most
impact on reducing medication errors at Hospital for Sick Children in
Toronto?
a. involvement of pharmacists in rounds
b. computerized screening for allergies
and interactions
c. initiation of unit dosing
d. computerized order entry
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Job Title

Address

Other

Specialty

Type of facility

City

State

Telephone

Zip
Fax

❏

Are you certified?
email

Yes

❏

No

Certified by

Registration Deadline: September 30, 2005

State of License (1)

License#

Contact Hours: 1.5

State of License (2)

License#

Fee: $12.95

Social Security

ANCC category: O

❏ From time to time we make our mailing list available to outside organizations to announce special offers. Please check here if you do not
wish us to release your name and address.

B Test Answers: Darken one for your answer to each question.
B

C

D

B

C

D

B

C

D

1. ❍

A

❍

❍

❍

6. ❍

❍

❍

❍

11. ❍

❍

❍

❍

2. ❍

❍

❍

❍

7. ❍

❍

❍

❍

12. ❍

❍

❍

❍

3. ❍

❍

❍

❍

8. ❍

❍

❍

❍

13. ❍

❍

❍

❍

4. ❍

❍

❍

❍

9. ❍

❍

❍

❍

14. ❍

❍

❍

❍

5. ❍

❍

❍

❍

10. ❍

❍

❍

❍

15. ❍

❍

❍

❍

A

C Course Evaluation∗
1. Did this CE activity’s learning objectives
relate to its general purpose?
2. Was the journal home study format an effective way to present the material?
3. Was the content relevant to your nursing
practice?
4. How long did it take you to complete this
CE activity?
hours
minutes
5. Suggestion for future topics

A

A

D Two Easy Ways to Pay:

B

❏

Yes

❏

No

❏

Yes

❏

No

❏

Yes

❏

No

❏

Check or money order enclosed
(Payable to Lippincott Williams & Wilkins)

❏

Charge my

Card #

❏

Mastercard

❏

Visa

❏

American Express

Exp. Date

Signature
∗

In accordance with the Iowa Board of Nursing Administrative rules
governing grievances, a copy of your evaluation of the CE offering
may be submitted directly to the Iowa Board of Nursing.

Need CE STAT? Visit www.NursingCenter.com for immediate results, other CE activities,
and your personalized CE planner tool!
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